134 related articles for article (PubMed ID: 3101732)
1. Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor.
Ball J; Malia RG; Greaves M; Preston FE
Br J Haematol; 1987 Jan; 65(1):95-100. PubMed ID: 3101732
[TBL] [Abstract][Full Text] [Related]
2. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
[TBL] [Abstract][Full Text] [Related]
3. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
Ruggeri ZM; Zimmerman TS
J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
[TBL] [Abstract][Full Text] [Related]
4. Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment.
Goudemand J; Samor B; Caron C; Jude B; Gosset D; Mazurier C
Br J Haematol; 1988 Feb; 68(2):227-33. PubMed ID: 3126793
[TBL] [Abstract][Full Text] [Related]
5. Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
Takahashi H
Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):357-65. PubMed ID: 6791293
[No Abstract] [Full Text] [Related]
6. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
7. [Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia A and von Willebrand's disease].
Takase T; Nishino M; Yasui M; Shima M; Yoshikawa N; Fukui H
Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1571-8. PubMed ID: 3937410
[No Abstract] [Full Text] [Related]
8. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
10. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
[TBL] [Abstract][Full Text] [Related]
11. Acquired von Willebrand's syndrome with lupus-like serology.
Igarashi N; Miura M; Kato E; Matsuda T; Itoh K; Abildgaard CF; Shimizu M; Koizumi S; Sato T; Taniguchi N
Am J Pediatr Hematol Oncol; 1989; 11(1):32-5. PubMed ID: 2496614
[TBL] [Abstract][Full Text] [Related]
12. Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).
Ruggeri ZM; Nilsson IM; Lombardi R; Holmberg L; Zimmerman TS
J Clin Invest; 1982 Nov; 70(5):1124-7. PubMed ID: 6982283
[TBL] [Abstract][Full Text] [Related]
13. DDAVP-induced changes of factor VIII-related activities and bleeding time in patients with von Willebrand's syndrome.
Schmitz-Huebner U; Balleisen L; Arends P; Pollmann H; Sutor AH
Haemostasis; 1980; 9(4):204-13. PubMed ID: 6772527
[TBL] [Abstract][Full Text] [Related]
14. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of the chromogenic assay of factor VIII in haemophilia A, and different variants of von Willebrand's disease.
Lethagen S; Ostergaard H; Nilsson IM
Scand J Haematol; 1986 Nov; 37(5):448-53. PubMed ID: 3101169
[TBL] [Abstract][Full Text] [Related]
16. Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases.
Sampson BM; Greaves M; Malia RG; Preston FE
Br J Haematol; 1983 Jun; 54(2):233-44. PubMed ID: 6405778
[TBL] [Abstract][Full Text] [Related]
17. Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.
Ruggeri ZM; Lombardi R; Gatti L; Bader R; Valsecchi C; Zimmerman TS
Blood; 1982 Dec; 60(6):1453-6. PubMed ID: 6982737
[TBL] [Abstract][Full Text] [Related]
18. A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications.
Hilbert L; Federici AB; Baronciani L; Dallagiovanna S; Mazurier C
Haematologica; 2004 Sep; 89(9):1128-33. PubMed ID: 15377475
[TBL] [Abstract][Full Text] [Related]
19. Von Willebrand factor multimer patterns in von Willebrand's disease.
Hoyer LW; Rizza CR; Tuddenham EG; Carta CA; Armitage H; Rotblat F
Br J Haematol; 1983 Nov; 55(3):493-507. PubMed ID: 6416288
[TBL] [Abstract][Full Text] [Related]
20. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
